USANA Health Sciences (NYSE:USNA) Trading Down 2.1% After Insider Selling

USANA Health Sciences, Inc. (NYSE:USNA) shares fell 2.1% on Friday following insider selling activity. The company traded as low as $29.79 and last traded at $29.73. 10,077 shares were traded during trading, a decline of 90% from the average session volume of 100,948 shares. The stock had previously closed at $30.37.

Specifically, insider Joshua Foukas sold 5,732 shares of the stock in a transaction that occurred on Wednesday, March 12th. The shares were sold at an average price of $32.54, for a total transaction of $186,519.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider David Mulham Mulham sold 3,234 shares of the firm’s stock in a transaction on Monday, March 10th. The shares were sold at an average price of $32.98, for a total transaction of $106,657.32. Following the transaction, the insider now directly owns 12,775 shares of the company’s stock, valued at $421,319.50. The trade was a 20.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on USNA shares. StockNews.com lowered USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. Sidoti downgraded USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 18th. Finally, DA Davidson lowered their target price on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating for the company in a research report on Thursday, February 27th.

USANA Health Sciences Stock Performance

The stock has a market cap of $566.27 million, a PE ratio of 10.50, a PEG ratio of 0.93 and a beta of 0.98. The stock has a fifty day moving average price of $32.67 and a 200 day moving average price of $36.01.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.15. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The business had revenue of $213.61 million for the quarter, compared to analysts’ expectations of $208.82 million. As a group, equities analysts anticipate that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of USNA. Barclays PLC lifted its stake in shares of USANA Health Sciences by 111.9% during the 3rd quarter. Barclays PLC now owns 27,737 shares of the company’s stock worth $1,052,000 after acquiring an additional 14,647 shares during the last quarter. Principal Financial Group Inc. boosted its stake in shares of USANA Health Sciences by 2.8% during the fourth quarter. Principal Financial Group Inc. now owns 53,603 shares of the company’s stock valued at $1,924,000 after purchasing an additional 1,480 shares during the period. Rhumbline Advisers increased its stake in USANA Health Sciences by 39.8% in the 4th quarter. Rhumbline Advisers now owns 49,390 shares of the company’s stock worth $1,773,000 after buying an additional 14,068 shares during the period. Geode Capital Management LLC lifted its holdings in USANA Health Sciences by 4.5% during the 3rd quarter. Geode Capital Management LLC now owns 297,120 shares of the company’s stock valued at $11,269,000 after buying an additional 12,898 shares in the last quarter. Finally, Pzena Investment Management LLC boosted its position in USANA Health Sciences by 3.6% in the 4th quarter. Pzena Investment Management LLC now owns 1,087,076 shares of the company’s stock valued at $39,015,000 after buying an additional 37,466 shares during the period. Hedge funds and other institutional investors own 54.25% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.